The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Strategic Pivot | Explore Cigna's bold move to divest its Medicare business, refocusing on core competencies and potentially reducing regulatory exposure in government healthcare programs. |
Financial Resilience | Delve into Cigna's robust Q1 2025 performance, exceeding expectations with adjusted EPS of $17.99 and revenue growth of 24% year-over-year. |
Market Expansion | Learn how Cigna's market share gains in the $300 billion Select employer segment and innovations in specialty pharmacy are driving long-term growth prospects. |
Future Outlook | Discover analysts' optimistic projections for Cigna, with price targets ranging from $339 to $382 and expectations of 10-14% CAGR in earnings per share. |
Metrics to compare | CI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCIPeersSector | |
---|---|---|---|---|
P/E Ratio | 16.7x | 34.3x | −0.5x | |
PEG Ratio | 0.36 | −0.22 | 0.00 | |
Price/Book | 2.1x | 4.0x | 2.6x | |
Price / LTM Sales | 0.3x | 1.5x | 3.0x | |
Upside (Analyst Target) | 19.1% | 29.9% | 52.6% | |
Fair Value Upside | Unlock | 8.8% | 8.7% | Unlock |